null

HNRNPDL Rabbit Polyclonal Antibody (CAB10721)

SKU:
CAB10721
Product Type:
Antibody
Reactivity:
Human
Mouse
Rat
Host Species:
Rabbit
Isotype:
IgG
Antibody Type:
Polyclonal Antibody
Research Area:
Epigenetics and Nuclear Signaling
  • Epigenetics and Nuclear Signaling Antibodies 1 Anti-HNRNPDL Antibody CAB10721
  • Epigenetics and Nuclear Signaling Antibodies 1 Anti-HNRNPDL Antibody CAB10721
€139 - €419
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

HNRNPDL Rabbit Polyclonal Antibody (CAB10721)

The HNRNPDL Polyclonal Antibody (CAB10721) is a vital tool for researchers studying HNRNPDL, a protein involved in RNA binding and processing. This antibody, generated in rabbits, exhibits high specificity and sensitivity when detecting HNRNPDL in human samples, making it an excellent choice for use in Western blot applications. By targeting the HNRNPDL protein, researchers can easily identify and study its function in various cellular processes, particularly in RNA metabolism and gene expression regulation.HNRNPDL, also known as heterogeneous nuclear ribonucleoprotein D-like, plays a crucial role in the post-transcriptional control of gene expression by binding to RNA molecules and influencing their processing and stability. Understanding the function of HNRNPDL is key to unraveling its impact on cellular activities such as mRNA splicing, transport, and translation.

Research on HNRNPDL can provide insights into its involvement in diseases like cancer, neurodegenerative disorders, and developmental abnormalities, offering potential therapeutic targets for intervention.With its exceptional performance and reliability, the HNRNPDL Polyclonal Antibody (CAB10721) is a valuable asset for investigators exploring the molecular mechanisms of RNA biology and its implications in various pathological conditions. By utilizing this antibody in their experiments, researchers can advance their understanding of HNRNPDL's role in cellular physiology and disease progression, paving the way for innovative discoveries and therapeutic developments.